|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0010346,
umls-concept:C0439849,
umls-concept:C0445223,
umls-concept:C0666743,
umls-concept:C0871261,
umls-concept:C0872146,
umls-concept:C1552599,
umls-concept:C1704632,
umls-concept:C1704787,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-8-27
|
|
pubmed:abstractText |
Infliximab is an effective therapy in adult patients with refractory and fistulizing Crohn's disease. Experience in children is still limited.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0269-2813
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
425-31
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12940928-Adolescent,
pubmed-meshheading:12940928-Antibodies, Monoclonal,
pubmed-meshheading:12940928-Child,
pubmed-meshheading:12940928-Child, Preschool,
pubmed-meshheading:12940928-Crohn Disease,
pubmed-meshheading:12940928-Female,
pubmed-meshheading:12940928-Follow-Up Studies,
pubmed-meshheading:12940928-Gastrointestinal Agents,
pubmed-meshheading:12940928-Humans,
pubmed-meshheading:12940928-Infusions, Intravenous,
pubmed-meshheading:12940928-Intestinal Fistula,
pubmed-meshheading:12940928-Male,
pubmed-meshheading:12940928-Retrospective Studies,
pubmed-meshheading:12940928-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Response to infliximab is related to disease duration in paediatric Crohn's disease.
|
|
pubmed:affiliation |
Dipartimento di Pediatria, Università di Firenze-Ospedale Meyer, Florence, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
